ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 0.1822 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1822 |
| March 31, 2026 | 0.0211 |
| December 31, 2025 | 1.596 |
| September 30, 2025 | 0.4206 |
| June 30, 2025 | 0.1581 |
| March 31, 2025 | 0.1132 |
| December 31, 2024 | 0.8623 |
| September 30, 2024 | 0.1972 |
| June 30, 2024 | 0.2009 |
| March 31, 2024 | 0.0994 |
| December 31, 2023 | 0.275 |
| September 30, 2023 | -0.3968 |
| June 30, 2023 | 0.0068 |
| March 31, 2023 | -0.2651 |
| December 31, 2022 | -0.2576 |
| September 30, 2022 | -0.1679 |
| June 30, 2022 | -0.2104 |
| March 31, 2022 | -0.7012 |
| December 31, 2021 | -0.2679 |
| September 30, 2021 | -0.09 |
| June 30, 2021 | -0.2735 |
| March 31, 2021 | -0.4153 |
| December 31, 2020 | -0.4192 |
| September 30, 2020 | -0.5354 |
| June 30, 2020 | -0.2692 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5666 |
| December 31, 2019 | -0.3433 |
| September 30, 2019 | -0.2877 |
| June 30, 2019 | -0.3807 |
| March 31, 2019 | -0.5925 |
| December 31, 2018 | -0.4976 |
| September 30, 2018 | -0.4971 |
| June 30, 2018 | -0.51 |
| March 31, 2018 | -0.44 |
| December 31, 2017 | -0.55 |
| September 30, 2017 | -0.53 |
| June 30, 2017 | -0.55 |
| March 31, 2017 | -0.72 |
| December 31, 2016 | -0.65 |
| September 30, 2016 | -0.61 |
| June 30, 2016 | -0.63 |
| March 31, 2016 | -0.45 |
| December 31, 2015 | -0.45 |
| September 30, 2015 | -0.39 |
| June 30, 2015 | -0.39 |
| March 31, 2015 | -0.40 |
| December 31, 2014 | -0.28 |
| September 30, 2014 | -0.25 |
| June 30, 2014 | -0.22 |
| March 31, 2014 | -0.19 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 2.812 |
| Agios Pharmaceuticals, Inc. | -1.693 |
| Biogen, Inc. | 0.6557 |
| Insmed, Inc. | -0.0609 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.50M |
| Revenue (Quarterly) | 307.96M |
| Total Expenses (Quarterly) | 276.46M |
| Enterprise Value | 4.195B |
| Gross Profit Margin (Quarterly) | 90.81% |
| Profit Margin (Quarterly) | 10.23% |
| Earnings Yield | 7.49% |
| Operating Earnings Yield | 1.70% |
| Normalized Earnings Yield | 7.494 |